Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancer
Phase 1
Recruiting
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000017715
- Lead Sponsor
- Osaka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Non curative operation 2)Active concomitant malignancy 3)History of severe anaphylaxies 4)Severe complications, such as heart failure, renal failure, liver failure, watery diarrhea, paresis of intestine, ileus and severe diabetes mellitus 5)With the jaundice or cirrhosis 6)Active infection 7)Pregnant or pregnant possibility 8)Severe mental disorder 9)Inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method